Strand Therapeutics

Strand Therapeutics is a clinical-stage biotechnology company headquartered in Boston, Massachusetts, founded by biological engineers out of MIT — including Jacob Becraft (CEO), Tasuku Kitada (President, Head of R&D), Ron Weiss and Darrell J. Irvine — around what the company describes as the first mRNA programming language. Strand engineers programmable genetic medicines across three named platforms: SignalPath LNPs for tissue-selective delivery of mRNA payloads, SignalLock RNA which restricts expression to target tissues and deactivates it elsewhere, and SignalScript RNA for self-replicating and circular RNA constructs. Its clinical pipeline includes STX-001, STX-003 (systemic tumor delivery, entering the clinic in 2026) and STX-005 (in vivo CAR T), targeting solid tumors, blood cancers and autoimmune disease. Strand operates no developer program and publishes no API, SDK, webhook or machine-readable specification of any kind; its corporate site is a static Webflow property behind Cloudflare with no content API, no feed and no sitemap. It is catalogued here because it appears in the API Evangelist secondary-market harvest backlog, and this profile records the honest zero.

Strand Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, mRNA, and Genetic Medicine.

Strand Therapeutics’ developer surface includes engineering blog and 14 more developer resources.

🌐 Visit website 📡 Source on GitHub
9.5/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyBiotechnologyLife SciencesmRNAGenetic MedicineImmuno-OncologyOncologyAutoimmuneCell TherapyClinical TrialsPharmaceuticalsHealthcare

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 9.5/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.4 / 17
Commercial Clarity 1.8 / 17
Operational Transparency 0.6 / 11
Governance 0.0 / 10
Discoverability 4.9 / 9
Regulatory Posture 1.9 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/strand-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Strand Therapeutics Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt
LLMsTxt

Build 1

SDKs, sample code, and the tooling you integrate with

GitHubOrganization
GitHubOrganization

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Contact
Contact

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy

Company 6

The organization behind the API

Website
Website
 About
About
 Blog
Blog
 Careers
Careers
 LinkedIn
LinkedIn
 Twitter
Twitter

Other 4

Properties that don't map to a standard resource type

Technology
Technology
 Pipeline
Pipeline
 CookiePolicy
CookiePolicy
 SecondaryMarket
SecondaryMarket

Source (apis.yml)

apis.yml Raw ↑ 
aid: strand-therapeutics
name: Strand Therapeutics
description: 'Strand Therapeutics is a clinical-stage biotechnology company headquartered in Boston, Massachusetts, founded
  by biological engineers out of MIT — including Jacob Becraft (CEO), Tasuku Kitada (President, Head of R&D), Ron Weiss and
  Darrell J. Irvine — around what the company describes as the first mRNA programming language. Strand engineers programmable
  genetic medicines across three named platforms: SignalPath LNPs for tissue-selective delivery of mRNA payloads, SignalLock
  RNA which restricts expression to target tissues and deactivates it elsewhere, and SignalScript RNA for self-replicating
  and circular RNA constructs. Its clinical pipeline includes STX-001, STX-003 (systemic tumor delivery, entering the clinic
  in 2026) and STX-005 (in vivo CAR T), targeting solid tumors, blood cancers and autoimmune disease. Strand operates no developer
  program and publishes no API, SDK, webhook or machine-readable specification of any kind; its corporate site is a static
  Webflow property behind Cloudflare with no content API, no feed and no sitemap. It is catalogued here because it appears
  in the API Evangelist secondary-market harvest backlog, and this profile records the honest zero.'
image: https://cdn.prod.website-files.com/695c147ac34bdf172346e992/695fc938e71f10c75f917b09_Screenshot%202026-01-08%20at%204.05.34%E2%80%AFPM%201.webp
url: https://raw.githubusercontent.com/api-evangelist/strand-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: enriched
x-tier-reason: enrichment pass 2026-08-05
specificationVersion: '0.20'
created: '2026-08-05'
modified: '2026-08-05'
tags:
- Company
- Biotechnology
- Life Sciences
- mRNA
- Genetic Medicine
- Immuno-Oncology
- Oncology
- Autoimmune
- Cell Therapy
- Clinical Trials
- Pharmaceuticals
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/strand-therapeutics-domain-security.yml
- type: Website
  url: https://www.strandtx.com/
- type: About
  url: https://www.strandtx.com/about
- type: Technology
  url: https://www.strandtx.com/technology
- type: Pipeline
  url: https://www.strandtx.com/pipeline
- type: Blog
  url: https://www.strandtx.com/articles
- type: Careers
  url: https://www.strandtx.com/careers
- type: Contact
  url: mailto:partnering@strandtx.com
- type: PrivacyPolicy
  url: https://www.strandtx.com/legal/privacy-policy
- type: CookiePolicy
  url: https://www.strandtx.com/legal/cookie-policy
- type: GitHubOrganization
  url: https://github.com/strand-therapeutics
- type: LinkedIn
  url: https://www.linkedin.com/company/strandtx/
- type: Twitter
  url: https://x.com/StrandTx
- type: SecondaryMarket
  url: https://forgeglobal.com/strand-therapeutics_stock/
- type: LLMsTxt
  url: llms/strand-therapeutics-llms.txt
x-enrichment:
  date: '2026-08-05'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Strand Therapeutics is a clinical-stage mRNA drug developer whose only web property is a static Webflow marketing
    site — no api./developer./docs./portal./mcp. subdomain resolves at all, and the site itself 404s on /openapi.json, /graphql,
    /wp-json/, /llms.txt and every /.well-known/ path.
  evidence:
  - url: https://www.strandtx.com/openapi.json
    status: 404
  - url: https://www.strandtx.com/.well-known/agent-card.json
    status: 404
  - url: https://www.strandtx.com/graphql
    status: 404
  - url: https://www.strandtx.com/wp-json/
    status: 404
  - url: https://www.strandtx.com/
    status: 200
  checked: '2026-08-05'